By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Life Care NewsLife Care NewsLife Care News
  • Home
  • Business
    • Business
  • News
  • Tech
  • Entertainment
  • Health
  • Education
  • Automobile
  • Sports
Search
Technology
  • Advertise
  • Advertise
Health
Entertainment
  • Home
  • Business
    • Business
  • News
  • Tech
  • Entertainment
  • Health
  • Education
  • Automobile
  • Sports
  • Advertise
  • Advertise
Copyright © 2015 - 2024 LifeCareNews Network. All Rights Reserved.
LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Reading: Game-Changing Medical Demonstration Poised to Rewrite Theranos Story
Share
Notification Show More
Font ResizerAa
Life Care NewsLife Care News
Font ResizerAa
  • Education
  • Automobile
  • Entertainment
  • News
  • Tech
  • Sports
Search
  • Home
  • Home
    • Home 1
    • Default Home 5
  • Categories
  • Categories
    • Tech
    • Entertainment
    • Automobile
    • Sports
    • Education
    • News
    • Health
  • Bookmarks
  • Bookmarks
  • More Foxiz
    • Sitemap
  • More Foxiz
    • Sitemap
Follow US
  • Advertise
  • Advertise
Copyright © 2015 - 2024 LifeCareNews Network. All Rights Reserved. LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Health

Game-Changing Medical Demonstration Poised to Rewrite Theranos Story

GlobeNews Wire
Last updated: 22/04/2025 5:56 AM
GlobeNews Wire
Share
4 Min Read
Game-Changing Medical Demonstration Poised to Rewrite Theranos Story
SHARE
Game-Changing Medical Demonstration Poised to Rewrite Theranos Story

Ryan El-Hosseiny Declares Elizabeth Holmes Was Right All Along—And Plans to Prove It Live!

April 21, 2025 17:06 ET  | Source: Filmmaker Ryan El-Hosseiny


MIAMI BEACH, Fla., April 21, 2025 (GLOBE NEWSWIRE) — In a moment destined to shake the foundation of modern medicine—and perhaps the U.S. justice system—visionary medical innovator Ryan El-Hosseiny is making a bold and unprecedented claim: Elizabeth Holmes was right all along. And tomorrow, during a highly anticipated live demonstration in Miami Beach, he intends to prove it.

Timed deliberately to coincide with Medical Laboratory Professionals Week (April 20–26), this explosive revelation is not just about clearing a name—it’s about completely disrupting the current blood testing industry and reigniting a global conversation about what’s truly possible in diagnostic science. “The world was too quick to crucify innovation,” says El-Hosseiny. “But I’m here to finish what Theranos started—this time, with the science and U.S. trial exhibits to back it up.”

El-Hosseiny’s upcoming demonstration, leading up to the release of his movie titled “Just Blood”, will unveil next-generation blood testing technology that he asserts will validate the Theranos vision and expose deep flaws in the prosecution’s case against Holmes. The livestream event promises to be equal parts scientific breakthrough and media firestorm, with members of the medical, legal, and tech communities watching closely.

Often dubbed the “Steve Jobs of medical labs,” El-Hosseiny is no stranger to innovation—or controversy. As the inventor of a revolutionary safety lancet and the holder of a U.S. patent for a novel blood collection device, he has already transformed clinical efficiency and safety standards nationwide.

As former CEO of Access Medical Laboratories, one of the most advanced diagnostics labs in the country, El-Hosseiny led the construction of a cutting-edge 25,000-square-foot facility and drove major expansions in cardiac, endocrinological, and microbiological testing.

And his talents don’t stop at the lab. He’s also an award-winning filmmaker, with his Oscar-contending short film Chasing Titles Vol. 1 racking up 45 wins and 23 nominations—a testament to his bold storytelling and visionary execution across disciplines.

THE DEMONSTRATION

The live demonstration is scheduled for 8:30PM EST. on April 22nd at 4441 Collins Ave, Miami Beach, FL 33140, placing science in the spotlight under Miami’s bright lights. El-Hosseiny’s team claims this breakthrough will challenge conventional blood testing norms, drastically reduce sample size needs, and deliver real-time results with game-changing precision. But beyond the science lies something even bigger: a shot at rewriting history. “This isn’t about proving a point,” says El-Hosseiny. “It’s about setting the record straight, opening the door to a new medical era, and making sure we never again punish progress before understanding it.”

MEDIA RSVP & LIVESTREAM DETAILS

Members of the press are invited to attend in person or request credentials for the livestream. To RSVP, receive media access, or schedule interviews, contact: Emily Pantelides: 904-477-2306 emily@PantelidesPR.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/56e2eb9d-bbaa-4a9d-aa90-44ecc74851ac

You Might Also Like

Lifeward Announces Postponement of its Extraordinary General Meeting of Shareholders

RAMSAY SANTE : closing repricing 250217

Olympic values in action: empowering women and young people in Saudi Arabia

Attruby (acoramidis), a Near Complete TTR Stabilizer (90%), approved by FDA to Reduce Cardiovascular Death and Cardiovascular-related Hospitalization in ATTR-CM Patients

JuicyChat.AI Redefines NSFW AI Anime Ecosystem, Closes Loop for Creators

TAGGED:AdventureaprilbeachboldclaimdestinedelhosseinyelizabethfilmmakerflafoundationglobeholmesinnovatorjusticemakingmedicalmedicineandmiamimodernmomentnewswireperhapsrightryanScienceshakesourcesystemvisionaryunprecedented

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.

By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
Share This Article
Facebook Twitter Copy Link Print
Share
Previous Article Resmed Names Salli Schwartz as Chief Investor Relations Officer Resmed Names Salli Schwartz as Chief Investor Relations Officer
Next Article Scorpius Holdings Receives NYSE American Notice of Delisting and Reports Plans to Appeal Scorpius Holdings Receives NYSE American Notice of Delisting and Reports Plans to Appeal

Stay Connected

FacebookLike
TwitterFollow
PinterestPin
InstagramFollow
YoutubeSubscribe
Google NewsFollow
LinkedInFollow
MediumFollow
- Advertisement -

Latest News

Lipella Pharmaceuticals Issues Letter from the CEO to Stockholders Following Nasdaq Delisting
Lipella Pharmaceuticals Issues Letter from the CEO to Stockholders Following Nasdaq Delisting
Health 26/06/2025
MEME COINS INC., a Controlled Subsidiary of DOGP, to Acquire 2 Billion DOG Tokens from Tipestry
MEME COINS INC., a Controlled Subsidiary of DOGP, to Acquire 2 Billion DOG Tokens from Tipestry
Health 26/06/2025
Bondholders approve amended terms of the 2025 and 2028 convertible bonds
Bondholders approve amended terms of the 2025 and 2028 convertible bonds
Health 26/06/2025
Gold H2 Delivers First Successful Subsurface Bio-Stimulated Hydrogen Production Field Trial
Gold H2 Delivers First Successful Subsurface Bio-Stimulated Hydrogen Production Field Trial
Health 26/06/2025
//

We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.

Quick Link

  • About Us
  • Contact Us
  • Editorial Guidelines
  • Privacy Policy
  • Terms and Conditions

Top Categories

  • Automobile
  • Education
  • Entertainment
  • Health
  • News
  • Sports
  • Tech

Sign Up for Our Newsletter

Subscribe to our newsletter to get our newest articles instantly!

Life Care NewsLife Care News
Follow US
Copyright © 2015 - 2024 LifeCareNews Network. All Rights Reserved. LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Join Us!
Subscribe to our newsletter and never miss our latest news, podcasts etc..

Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?